Orthofix International N.V. (NASDAQ:OFIX) – Analysts at Gabelli increased their FY2017 earnings estimates for shares of Orthofix International N.V. in a research report issued to clients and investors on Wednesday. Gabelli analyst J. Tsai now anticipates that the medical device company will earn $1.60 per share for the year, up from their previous forecast of $1.55. Gabelli also issued estimates for Orthofix International N.V.’s FY2018 earnings at $1.80 EPS, FY2019 earnings at $2.00 EPS and FY2021 earnings at $2.35 EPS.

A number of other research analysts also recently commented on OFIX. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, July 6th. BidaskClub downgraded shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. TheStreet upgraded shares of Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. Jefferies Group LLC restated a “buy” rating and issued a $55.00 price target (up from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. Finally, BTIG Research set a $56.00 price target on shares of Orthofix International N.V. and gave the stock a “buy” rating in a research report on Monday. Seven research analysts have rated the stock with a buy rating, Orthofix International N.V. currently has a consensus rating of “Buy” and an average price target of $54.42.

ILLEGAL ACTIVITY WARNING: “Orthofix International N.V. (OFIX) to Post FY2017 Earnings of $1.60 Per Share, Gabelli Forecasts” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://www.americanbankingnews.com/2017/11/02/orthofix-international-n-v-ofix-to-post-fy2017-earnings-of-1-60-per-share-gabelli-forecasts.html.

Orthofix International N.V. (NASDAQ:OFIX) last announced its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Orthofix International N.V. had a net margin of 0.33% and a return on equity of 10.26%. The firm had revenue of $105.30 million during the quarter, compared to analysts’ expectations of $100.67 million. During the same period in the previous year, the company earned $0.36 earnings per share. Orthofix International N.V.’s quarterly revenue was up 6.9% compared to the same quarter last year.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Orthofix International N.V. by 18.6% in the 1st quarter. Vanguard Group Inc. now owns 1,815,948 shares of the medical device company’s stock worth $69,278,000 after purchasing an additional 284,482 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Orthofix International N.V. by 11.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 870,120 shares of the medical device company’s stock worth $40,443,000 after purchasing an additional 90,349 shares during the last quarter. State Street Corp grew its stake in shares of Orthofix International N.V. by 4.1% in the 2nd quarter. State Street Corp now owns 481,220 shares of the medical device company’s stock worth $22,370,000 after purchasing an additional 18,741 shares during the last quarter. Northern Trust Corp grew its stake in shares of Orthofix International N.V. by 5.8% in the 2nd quarter. Northern Trust Corp now owns 350,019 shares of the medical device company’s stock worth $16,269,000 after purchasing an additional 19,253 shares during the last quarter. Finally, Teachers Advisors LLC grew its stake in shares of Orthofix International N.V. by 15.9% in the 2nd quarter. Teachers Advisors LLC now owns 320,404 shares of the medical device company’s stock worth $14,892,000 after purchasing an additional 44,064 shares during the last quarter. 93.80% of the stock is currently owned by institutional investors.

In other Orthofix International N.V. news, CFO Rice Doug sold 7,353 shares of the firm’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $49.46, for a total transaction of $363,679.38. Following the transaction, the chief financial officer now owns 44,743 shares of the company’s stock, valued at approximately $2,212,988.78. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Brad Mason sold 2,733 shares of the firm’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $48.10, for a total transaction of $131,457.30. Following the transaction, the chief executive officer now directly owns 188,053 shares in the company, valued at approximately $9,045,349.30. The disclosure for this sale can be found here. Over the last quarter, insiders sold 23,406 shares of company stock worth $1,138,531. 5.60% of the stock is currently owned by insiders.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Earnings History and Estimates for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.